China Patient Monitoring Market Size (2024 - 2029)

The China Patient Monitoring Market is projected to experience significant growth over the forecast period, driven by the increasing prevalence of chronic diseases and the rising demand for continuous monitoring. The market's expansion is further supported by the growing geriatric population and the critical role of patient monitoring during the COVID-19 pandemic, which highlighted the importance of remote health monitoring technologies. Despite these positive trends, the market's growth may be hindered by the high cost of technology and a stringent regulatory environment.

Market Size of China Patient Monitoring Industry

China Patient Monitoring Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 2.47 Billion
Market Size (2029) USD 3.53 Billion
CAGR (2024 - 2029) 7.41 %
Market Concentration Medium

Major Players

China Patient Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

China Patient Monitoring Market Analysis

The China Patient Monitoring Market size is estimated at USD 2.47 billion in 2024, and is expected to reach USD 3.53 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029).

The pandemic significantly impacted the patient monitoring market in China during the initial stages of the COVID-19 outbreak. As per the BMJ article published in February 2021, in China, remote health monitoring devices, mobile telecom devices, and cloud video services are used to collect and transmit information about patients in some isolation wards. The report also mentioned that wireless health monitoring equipment was used to monitor the patient's vital signs in the isolation wards in China. Thus, the usage of patient monitoring in managing COVID-19-infected patients in China during the pandemic had a crucial impact on the market growth. In addition, the demand for patient monitoring is expected to remain intact due to the rising focus on chronic diseases in patients during the post-pandemic period, fueling the market growth over the forecast period.

The increasing prevalence of chronic disease among the Chinese population, along with the rising demand for continuous monitoring, the increasing geriatric population is expected to contribute to the growth of the market. According to the NCBI article published in February 2022, asthma is a major public health challenge in China, with a national prevalence of asthma of 4.2%, representing 45.7 million Chinese adults. Such increasing prevalence of chronic disorders and various other injuries among the Chinese population is expected to drive the demand for patient monitoring owing to the effective management of these diseases, thereby fueling the market's growth.

However, the high cost of technology and stringent regulatory framework is expected to restrain the market's growth over the forecast period.

China Patient Monitoring Industry Segmentation

As per the report's scope, patient monitoring devices continuously monitor the patient's vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. China Patient Monitoring Market is Segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Multi-parameter Monitors, and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Devices), End User (Home Care Settings, Hospital and Clinics, and Other End Users). The report offers the value (in USD million) for the above segments.

By Type of Device
Hemodynamic Monitoring Devices
Neuromonitoring Devices
Cardiac Monitoring Devices
Respiratory Monitoring Devices
Multi-parameter Monitors
Other Types of Devices
By Application
Cardiology
Neurology
Respiratory
Fetal and Neonatal
Weight Management and Fitness Monitoring
Other Applications
By End User
Home Healthcare
Hospitals and Clinics
Other End Users
Need A Different Region Or Segment?
Customize Now

China Patient Monitoring Market Size Summary

The China Patient Monitoring Market is poised for significant growth over the forecast period, driven by the increasing prevalence of chronic diseases and the rising geriatric population. The market experienced a notable impact during the COVID-19 pandemic, where the use of remote health monitoring devices and wireless equipment became crucial in managing infected patients. This trend has continued post-pandemic, with a sustained demand for patient monitoring solutions to address chronic conditions. The market's expansion is further supported by the growing need for continuous monitoring, particularly in managing cardiovascular and neurological disorders. Despite the high cost of technology and a stringent regulatory framework posing challenges, the market is expected to thrive due to the effective management of health conditions through advanced monitoring systems.

The demand for patient monitoring devices is particularly strong in the cardiovascular and neurology segments, driven by the increasing prevalence of heart diseases and neurological disorders such as Alzheimer's and epilepsy. The aging population in China, which is more susceptible to these conditions, further fuels the market's growth. Major players in the industry, including Johnson & Johnson, Abbott Laboratories, and GE Healthcare, are actively contributing to market development through innovative product launches and strategic partnerships. For instance, Mindray's introduction of the mWear system for wireless, wearable monitoring highlights the industry's focus on addressing healthcare challenges like bed and staff shortages. These developments underscore the dynamic nature of the China Patient Monitoring Market, with a fragmented landscape characterized by the presence of several key players.

Explore More

China Patient Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Incidences of Chronic Diseases due to Lifestyle Changes

      2. 1.2.2 Growth in Geriatric Population

      3. 1.2.3 Growing Preference for Home and Remote Monitoring

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Technology

      2. 1.3.2 Stringent Regulatory Framework

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type of Device

      1. 2.1.1 Hemodynamic Monitoring Devices

      2. 2.1.2 Neuromonitoring Devices

      3. 2.1.3 Cardiac Monitoring Devices

      4. 2.1.4 Respiratory Monitoring Devices

      5. 2.1.5 Multi-parameter Monitors

      6. 2.1.6 Other Types of Devices

    2. 2.2 By Application

      1. 2.2.1 Cardiology

      2. 2.2.2 Neurology

      3. 2.2.3 Respiratory

      4. 2.2.4 Fetal and Neonatal

      5. 2.2.5 Weight Management and Fitness Monitoring

      6. 2.2.6 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Home Healthcare

      2. 2.3.2 Hospitals and Clinics

      3. 2.3.3 Other End Users

China Patient Monitoring Market Size FAQs

The China Patient Monitoring Market size is expected to reach USD 2.47 billion in 2024 and grow at a CAGR of 7.41% to reach USD 3.53 billion by 2029.

In 2024, the China Patient Monitoring Market size is expected to reach USD 2.47 billion.

China Patient Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)